Dihydrotanshinone I Inhibits the Proliferation and Growth of Oxaliplatin-Resistant Human HCT116 Colorectal Cancer Cells

Oxaliplatin (OXA) is a first-line chemotherapeutic drug for the treatment of colorectal cancer (CRC), but acquired drug resistance becomes the main cause of treatment failure. Increasing evidence has shown that some natural components may serve as chemoresistant sensitizers. In this study, we discov...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mengge, Xiang, Yusen, Wang, Ruyu, Zhang, Lijun, Zhang, Hong, Chen, Hongzhuan, Luan, Xin, Chen, Lili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692243/
https://www.ncbi.nlm.nih.gov/pubmed/36431875
http://dx.doi.org/10.3390/molecules27227774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692243/
https://www.ncbi.nlm.nih.gov/pubmed/36431875
http://dx.doi.org/10.3390/molecules27227774

Ejemplares similares